Healthcare Bizdev
HCBD-Pro Services Client Subscribers

HCBD-PRO Services

Query News -

Welcome <Guest> Login
Fresenius Health Partners | Fresenius Medical Care
 
920 Winter St.
Waltham , MA   02451-1457   USA
781-699-2825
1-888-877-3625
 
Company Website:
http://www.fmchp.com
Contact the Company
Company Hierarchy
Subsidiary(s)/ Affiliate(s)

 
Business Focus:
Health Promotion, Productivity and Wellness
Company Description:
Fresenius Health Partners is an URAQ and NCQA accredited integrated care management company providing specialized services to kidney patients. Chronic Kidney Disease (CKD) is a public health problem affecting roughly 20 million American adults. The spectrum of CKD includes five stages of disease, beginning with individuals with mild kidney damage progressing through those with kidney failure, more commonly referred to as End Stage Renal Disease (ESRD).ESRD patients have multiple risk factors and complicating conditions in addition to their kidney disease and need for dialysis treatments.

  • Cardiovascular Disease and Hypertension
  • Diabetes and Peripheral Vascular Disease (PVD)
  • Infection Risk
  • Malnutrition

ESRD is a key target for integrated care management for the following reasons:

  • Cost per patient is the highest of any chronic disease category, in excess of $100,000 per year.
  • Hospitalizations from complicating conditions can represent 30% to 40% of this annual cost per patient.

ESRD patients interact with many types of providers (PCPs, nephrologists, dialysis units, specialists, hospitals, etc. . .) and will benefit from a significant coordination of care available through the nurse care manager. Save costs and improve patient care and satisfaction? It's not only possible --we’ve proven it. The Fresenius Health Partners program is a smart and modest investment by a health plan payer to raise the standard of care on their highest cost segment of members: chronic kidney dialysis patients. Raising the standard of care with an investment in Fresenius Health Partners will also lower the total treatment costs delivering validated return on investment.

An insurance company payer's investment in the Fresenius Health Partners program is modest, but the return on investment (ROI) is significant. Our program has consistently delivered a 5 to 1 savings to investment ratio for our customers. And just as important, we have demonstrated improved outcomes, lower mortality and reduced hospitalization, for our customer's members with kidney disease.

We can contract directly with an insurance company payer or we can work with you and your dialysis provider to have the Fresenius Health Partners program included and billed as part of your contracted dialysis treatment costs.

 
Company Ownership:
Fresenius Health Partners (PPO SNP) is a subsidiary of Fresenius Medical Care.

Company Contacts:
Media Contact(s)
Jonathan Stone
[Vice President of Communications]
 
Jane Hauser
[Media Contact]
 

Company Officials:
Donna McCarthy
[West Division President]
 
Peter F. Sauer MEd
[President]
 
Robert Kossmann
[Chief Medical Officer]
 
Franklin Maddux
[Chief Medical Officer]
 
Thomas Dunn D.O.
[Medical Director]
 
Ahmad Sharif MD, MPH
[Vice President - Clinical Health Information Technology]
 
Jeff Burbank
[Chief Technology Officer]
 
Angela McClure
[Chief Experience Officer]
 
Jeanne Karalus
[Senior Manager - Marketing and Program Management]
 
Joe Turk
[President for Renal Therapies Group]
 
View Additional Employees and Representatives

Company News/Coverage:
Fresenius Medical Care Sees U.S. Plans for Changes to Kidney Disease Care as Positive Reinforcement of Company’s Strategy
FMCNA Announces Leadership Additions Following NxStage Merger
Fresenius Medical Care: Introducing the 2018 FMCNA Annual Medical Report
Fresenius Medical Care Completes Divestment of Sound Inpatient Physicians Holdings
Fresenius Medical Care North America Appoints Angela McClure to Chief Experience Officer
View all remaining Company News/Coverage headlines
About Us | Purchase Pro | Contact Us

© 2006-2010 Healthcare BizDev, Inc. All rights reserved. Privacy Policy | Legal Conditions